Table 4.
Prevalence (% and 95%CI) of albuminuria and renal impairment by age group and gender in DRUID and AusDiab participants
| DRUID | AusDiab | |||
|---|---|---|---|---|
| M | F | M | F | |
| Albuminuria* | ||||
| 15-24 years | 5.3 (1-13) | 5.8 (3-11) | - | - |
| 25-34 years | 3.6 (1-12) | 12.4 (7-19) | 2.2 (1-4) | 3.1 (2-5)† |
| 35-44 years | 23.9 (14-36) | 11.9 (7-18) | 3.6 (3-5) † | 3.3 (2-4) † |
| 45-54 years | 22.9 (12-37) | 25.2 (17-35) | 4.6 (4-6) † | 5.0 (4-6) † |
| 55-64 years | 33.3 (15-57) | 21.6 (11-35) | 10.0 (8-12)** | 5.4 (4-7) † |
| 65-74 years | 33.3 (4-77) | 28.0 (12-49) | 16.5 (14-19) | 9.3 (8-12)** |
| Renal | ||||
| Impairment* | ||||
| 15-24 years | 0 | 0 | - | - |
| 25-34 years | 0 | 0.8 (0-4) | 0.2 (0-1) | 0.6 (0-1) |
| 35-44 years | 3.0 (0-10) | 0.7 (0-4) | 0.7 (0-1) | 1.3 (1-2) |
| 45-54 years | 6.3 (0-17) | 5.6 (2-12) | 2.8 (2-4) | 5.4 (4-7) |
| 55-64 years | 9.5 (1-30) | 7.8 (2-19) | 4.7 (3-6) | 9.6 (8-11) |
| 65-74 years | 16.7 (0-64) | 4.0 (0-20) | 18.0 (15-21) | 27.3 (24-31)** |
*DRUID n = 76,139; 56,129; 67,135; 48,107; 21,51; 6,25. AusDiab n = 585,775; 1086,1417; 1337,1488; 912,1027; 723,772. (for men, women respectively for each age group in ascending order)
**p < 0.05, †p < 0.001: for AusDiab compared to DRUID participants of the same gender for each age group